MARION, N.C., Feb. 21, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE --Greene Concepts, Inc. (USOTC: INKW) announced today that Susan Hewlings, PhD, RD, has been appointed as the Company’s Director of Scientific Formulations.
Dr. Hewlings brings over 20 years in nutrition, sports nutrition, and scientific consulting for the dietary supplement and medical industries. She has a Ph.D. in Nutrition, a M.S. in Exercise Physiology from Florida State University, and is a Registered Dietitian. Dr. Hewlings is a full-time professor at Central Michigan University and Co-Founder of Substantiation Sciences LLC where she assists companies in supporting their market launch strategies with scientific evidence. She is the author of Nutrition: Real People, Real Choices and has published multiple articles on dietary supplements, pharmacokinetics, and nutrition in peer-reviewed medical journals.
Karen Howard, CEO of Greene Concepts Inc., stated, “We are very fortunate to have someone of Dr. Hewlings caliber join our company. Dr. Hewlings brings with her a wealth of talent to our growing team. Dr. Hewlings background, knowledge and expertise of nutrition and dietary supplementation will greatly enhance our company as well as the products that we provide to our customers.”
Dr. Hewlings stated, “I am very pleased to become a part of the Greene Concepts team and very excited to have the opportunity to collaborate on work efforts with Ms. Howard. We look forward to developing and bringing to market new and exciting beverage options for consumers that are scientifically formulated to provide enhanced life experiences for any lifestyle.”
About Greene Concepts, Inc. and Mammoth Ventures Inc.
Greene Concepts, Inc. (http://www.greeneconcepts.com/) is a publicly traded company and thru its newly acquired wholly-owned subsidiary Mammoth Ventures Inc. has entered into the specialty beverage and bottling business.
Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.